Details

Autor(en) / Beteiligte

• Rogava, Meri
• Aprati, Tyler J
• Chi, Wei-Yu
• Melms, Johannes C
• Hug, Clemens
• Davis, Stephanie H
• Earlie, Ethan M
• Chung, Charlie
• Deshmukh, Sachin K
• Wu, Sharon
• Sledge, George
• Tang, Stephen
• Ho, Patricia
• Amin, Amit Dipak
• Caprio, Lindsay
• Gurjao, Carino
• Tagore, Somnath
• Ngo, Bryan
• Lee, Michael J
• Zanetti, Giorgia
• Wang, Yiping
• Chen, Sean
• Ge, William
• Melo, Luiza Martins Nascentes
• Allies, Gabriele
• Rösler, Jonas
• Gibney, Goeffrey T
• Schmitz, Oliver J
• Sykes, Megan
• Creusot, Rémi J
• Tüting, Thomas
• Schadendorf, Dirk
• Röcken, Martin
• Eigentler, Thomas K
• Molotkov, Andrei
• Mintz, Akiva
• Bakhoum, Samuel F
• Beyaz, Semir
• Cantley, Lewis C
• Sorger, Peter K
• Meckelmann, Sven W
• Tasdogan, Alpaslan
• Liu, David
• Laughney, Ashley M
• Izar, Benjamin

Titel

Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation

Ist Teil von

• Nature cancer, 2024-03, Vol.5 (3), p.433

Ort / Verlag

England

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Liver metastasis (LM) confers poor survival and therapy resistance across cancer types, but the mechanisms of liver-metastatic organotropism remain unknown. Here, through in vivo CRISPR-Cas9 screens, we found that Pip4k2c loss conferred LM but had no impact on lung metastasis or primary tumor growth. Pip4k2c-deficient cells were hypersensitized to insulin-mediated PI3K/AKT signaling and exploited the insulin-rich liver milieu for organ-specific metastasis. We observed concordant changes in PIP4K2C expression and distinct metabolic changes in 3,511 patient melanomas, including primary tumors, LMs and lung metastases. We found that systemic PI3K inhibition exacerbated LM burden in mice injected with Pip4k2c-deficient cancer cells through host-mediated increase in hepatic insulin levels; however, this circuit could be broken by concurrent administration of an SGLT2 inhibitor or feeding of a ketogenic diet. Thus, this work demonstrates a rare example of metastatic organotropism through co-optation of physiological metabolic cues and proposes therapeutic avenues to counteract these mechanisms.